Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Hypersensitivity Reaction

  Free Subscription


3 Allergy
1 Am J Respir Crit Care Med
12 Ann Allergy Asthma Immunol
3 Arerugi
1 BMC Pediatr
8 Br J Dermatol
1 Chest
2 Clin Immunol
9 Contact Dermatitis
1 Dermatology
4 Int Arch Allergy Immunol
6 J Allergy Clin Immunol
1 Lancet
3 PLoS One
1 Proc Natl Acad Sci U S A
3 Respir Med

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. VOSKAMP AL, Khosa S, Phan T, DeBerg HA, et al
    Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy.
    Allergy. 2023 Dec 19. doi: 10.1111/all.15966.
    PubMed         Abstract available

  2. GUTTMAN-YASSKY E, Facheris P, Gomez-Arias PJ, Del Duca E, et al
    Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis.
    Allergy. 2023 Dec 18. doi: 10.1111/all.15969.
    PubMed         Abstract available

  3. BASU MN, Melchiors BB, Mortz CG, Garvey LH, et al
    Hypersensitivity reactions to human albumin-A case series and diagnostic algorithm.
    Allergy. 2023 Dec 16. doi: 10.1111/all.15971.

    Am J Respir Crit Care Med

  4. TRISOLINI R, Pasciuto G, Cancellieri A, Agrosi C, et al
    Peripheral Airway Sarcoidosis: Seeing What Was Previously Invisible.
    Am J Respir Crit Care Med. 2023;208:1328-1329.

    Ann Allergy Asthma Immunol

  5. MAATTA AM, Malmberg LP, Pelkonen AS, Makela MJ, et al
    The link between early childhood lower airway symptoms, airway hyperresponsiveness, and school-age lung function.
    Ann Allergy Asthma Immunol. 2024;132:54-61.
    PubMed         Abstract available

  6. FINEMAN S, Knox S, Lee GB, Hernandez-Trujillo V, et al
    From the Pages of AllergyWatch.
    Ann Allergy Asthma Immunol. 2023 Dec 13:S1081-1206(23)01491.

  7. FINEMAN S, Chow T, Joshi SR, Lee GB, et al
    From the Pages of AllergyWatch.
    Ann Allergy Asthma Immunol. 2023 Dec 13:S1081-1206(23)01492.

  8. SACTA MA, Alsaati N, Spergel J
    Anaphylaxis: A 2023 practice parameter update: Major changes in management of anaphylaxis.
    Ann Allergy Asthma Immunol. 2023 Nov 16:S1081-1206(23)01382.

  9. GOLDEN DBK, Wang J, Waserman S, Akin C, et al
    Anaphylaxis: A 2023 practice parameter update.
    Ann Allergy Asthma Immunol. 2023 Dec 5:S1081-1206(23)01304.
    PubMed         Abstract available

  10. CHU DK, Schneider L, Asiniwasis RN, Boguniewicz M, et al
    Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.
    Ann Allergy Asthma Immunol. 2023 Dec 18:S1081-1206(23)01455.
    PubMed         Abstract available

  11. ADAMS KE, Smith D, Weiss S, White K, et al
    Military Accession Guidelines: An Allergy Focus.
    Ann Allergy Asthma Immunol. 2023 Dec 16:S1081-1206(23)01499.
    PubMed         Abstract available

  12. LI JC, Rotter NS, Stieb ES, Stockbridge JL, et al
    Utility of food allergy thresholds.
    Ann Allergy Asthma Immunol. 2023 Dec 17:S1081-1206(23)01497.
    PubMed         Abstract available

    Trials and tribulations of managing pediatric and adolescent asthma.
    Ann Allergy Asthma Immunol. 2024;132:1-2.

  14. SHAKER M, Golden DBK
    More than 80 years of excellence and collaboration in allergy ... and just getting started.
    Ann Allergy Asthma Immunol. 2024;132:3-4.

  15. ROSAS-SALAZAR C, Bacharier LB
    The biologic asthma response score: A blueprint to address biologic failure in severe asthma?
    Ann Allergy Asthma Immunol. 2024;132:7-8.

  16. CECCHI L, Poncet P, Maltagliati L, Carli G, et al
    Optimization of the diagnosis and characterization of gibberellin-regulated protein sensitization: An Italian cohort study.
    Ann Allergy Asthma Immunol. 2024;132:82-90.
    PubMed         Abstract available


    Arerugi. 2023;72:1193-1197.

  18. YUTA A, Ogawa Y, Kozaki H, Shimizu T, et al
    Arerugi. 2023;72:1230-1239.
    PubMed         Abstract available

  19. ITONAGA T, Yanagida N, Nishino M, Sato S, et al
    Arerugi. 2023;72:1240-1247.
    PubMed         Abstract available

    BMC Pediatr

  20. XU M, Zhou L, Zhang J, Luo S, et al
    Neutrophil to lymphocyte ratio in pediatric patients with asthmatic exacerbation and community-acquired pneumonia.
    BMC Pediatr. 2023;23:640.
    PubMed         Abstract available

    Br J Dermatol

  21. Nemolizumab reduces itch and improves other signs of atopic dermatitis in children aged 6-12 years.
    Br J Dermatol. 2023;190:e2.

  22. Greater understanding about differences in the long-term course of eczema and their risk factors in children.
    Br J Dermatol. 2023;190:e5.

  23. A study about how many people around the world have atopic dermatitis.
    Br J Dermatol. 2023;190:e6.

  24. The role of enhancers in eczema and psoriasis.
    Br J Dermatol. 2023;190:e1.

  25. TIERNEY E, Evans P, Broderick V, Wynn R, et al
    Successful response to dupilumab in a refractory case of atopic dermatitis-like chronic cutaneous graft-versus-host disease.
    Br J Dermatol. 2023 Dec 20:ljad526. doi: 10.1093.

  26. FORKEL S, Schubert S, Corvin L, Heine G, et al
    Contact allergies to dental materials in patients.
    Br J Dermatol. 2023 Dec 20:ljad525. doi: 10.1093.
    PubMed         Abstract available

  27. THOMAS KS, Howells L, Leshem YA, Simpson EL, et al
    How to use the HOME Core Outcome Set for atopic dermatitis trials - a users' guide.
    Br J Dermatol. 2023 Dec 20:ljad497. doi: 10.1093.
    PubMed         Abstract available

  28. ABDI P, Haq Z, Diaz MJ, Maibach HI, et al
    Infectious disease among adults with allergic contact dermatitis: A propensity score-matched case-control study.
    Br J Dermatol. 2023 Dec 19:ljad504. doi: 10.1093.


  29. MULLIN ML, Fernandez G, Marinescu DC, Zheng B, et al
    Impact of antigen exposure on outcomes and treatment response in fibrotic hypersensitivity pneumonitis.
    Chest. 2023 Dec 19:S0012-3692(23)05933-0. doi: 10.1016/j.chest.2023.
    PubMed         Abstract available

    Clin Immunol

  30. APPANNA R, Gargano D, Caputo A, De Bartolomeis F, et al
    Changes in mucosal IgG4(+)- and IL-10(+)-cell frequencies in adults with eosinophilic esophagitis on a two-food elimination diet.
    Clin Immunol. 2023;257:109853.
    PubMed         Abstract available

  31. ZHOU Y, Liu Z, Liu Y
    The potential roles and mechanisms of Chitinase-3-like-1 in the pathogenesis of type 2-biased airway diseases.
    Clin Immunol. 2023;257:109856.
    PubMed         Abstract available

    Contact Dermatitis

  32. CARE W, Delacour H, Vodovar D, Langrand J, et al
    Occupational vesicant-induced skin lesions.
    Contact Dermatitis. 2024;90:91-93.

  33. CHRISTIANSEN AG, Kinnerup MB, Carstensen O, Sommerlund M, et al
    Occupational exposure to epoxy components and risk of dermatitis: A registry-based follow-up study of the wind turbine industry.
    Contact Dermatitis. 2024;90:32-40.
    PubMed         Abstract available

  34. TEO YX, McCarthy S, McFadden JP, White IR, et al
    Co-sensitisation to rubber accelerators and surfactants in three healthcare workers.
    Contact Dermatitis. 2024;90:95-97.

  35. STEUNEBRINK IM, de Groot A, Rustemeyer T
    Presence of 2-hydroxyethyl methacrylate (HEMA) and other (meth)acrylates in nail cosmetics, and compliance with EU legislation: An online market survey.
    Contact Dermatitis. 2024;90:60-65.
    PubMed         Abstract available

  36. MAHROUS B, Dupire G, Anthony E, Ben-Said B, et al
    Acute generalized exanthematous pustulosis induced by Ambroxol confirmed by positive skin tests.
    Contact Dermatitis. 2024;90:98-99.

    Skin sensitization data for methyl esters of sulphonic acids-Corrections to published databases required.
    Contact Dermatitis. 2024;90:84-88.
    PubMed         Abstract available

  38. BOONCHAI W, Likittanasombat S, Viriyaskultorn N, Kanokrungsee S, et al
    Gender differences in allergic contact dermatitis to common allergens.
    Contact Dermatitis. 2023 Dec 18. doi: 10.1111/cod.14479.
    PubMed         Abstract available

  39. CASTELAIN F, Aubin F, Pelletier F
    Contact allergy to Butyrospermum parkii butter in a patient with cheilitis.
    Contact Dermatitis. 2023 Dec 20. doi: 10.1111/cod.14478.

  40. AGUADO VAZQUEZ A, Sanchez Motilla JM, Alonso Diez C, Villodre Lozano P, et al
    Allergic contact dermatitis from chromium after vein sclerosis with chromated glycerin.
    Contact Dermatitis. 2023 Dec 21. doi: 10.1111/cod.14491.


  41. LI MC, Wu CY, Chang YT, Lyu YS, et al
    Risk of type 1 diabetes mellitus in patients with atopic dermatitis: a nationwide population-based cohort study.
    Dermatology. 2023 Dec 20. doi: 10.1159/000535848.
    PubMed         Abstract available

    Int Arch Allergy Immunol

  42. SHIPTON EV, Foxcroft K, Dekker Nitert M, McIntyre HD, et al
    OFFSPRING: A SPRING Follow-Up Study Assessing the Efficacy of Maternal Probiotics and Allergic Disease in the Child.
    Int Arch Allergy Immunol. 2023 Dec 15:1-6. doi: 10.1159/000535179.
    PubMed         Abstract available

  43. EYICE KARABACAK D, Can A, Demir S, Yegit OO, et al
    How Does Pregnancy and Type of Delivery Affect the Clinical Course of Hereditary Angioedema?
    Int Arch Allergy Immunol. 2023;184:1216-1224.
    PubMed         Abstract available

  44. LAM L, Jiang M, Bacchi S, Kovoor J, et al
    Prevalence of Trimethoprim-Sulfamethoxazole Adverse Reaction Mislabelling in Australia.
    Int Arch Allergy Immunol. 2023;184:1225-1229.
    PubMed         Abstract available

  45. MAETA A, Takaoka Y, Hamada M, Nakano A, et al
    Development of an Oral Immunotherapy-Related Parental Burden Scale.
    Int Arch Allergy Immunol. 2023;184:1203-1215.
    PubMed         Abstract available

    J Allergy Clin Immunol

  46. MUNOZ-RUIZ M, Llorian M, D'Antuono R, Pavlova A, et al
    IFN-gamma-dependent interactions between tissue-intrinsic gammadelta T cells and tissue-infiltrating CD8 T cells limit allergic contact dermatitis.
    J Allergy Clin Immunol. 2023;152:1520-1540.
    PubMed         Abstract available

  47. CASALE TB, Ellis AK, Nowak-Wegrzyn A, Kaliner M, et al
    Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection.
    J Allergy Clin Immunol. 2023;152:1587-1596.
    PubMed         Abstract available

  48. MARELLA S, Sharma A, Ganesan V, Ferrer-Torres D, et al
    IL-13-induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis.
    J Allergy Clin Immunol. 2023;152:1550-1568.
    PubMed         Abstract available

  49. GLATTHARDT T, van Tilburg Bernardes E, Arrieta MC
    The mycobiome in atopic diseases: Inducers and triggers.
    J Allergy Clin Immunol. 2023;152:1368-1375.
    PubMed         Abstract available

  50. BARTHA I, Almulhem N, Santos AF
    Feast for Thought: A Comprehensive Review of Food Allergy 2021-2023.
    J Allergy Clin Immunol. 2023 Dec 12:S0091-6749(23)02414.
    PubMed         Abstract available

  51. YOSIPOVITCH G, Kim B, Luger T, Lerner E, et al
    Similarities and Differences in Peripheral Itch and Pain Pathways in Atopic Dermatitis.
    J Allergy Clin Immunol. 2023 Dec 14:S0091-6749(23)02449.
    PubMed         Abstract available


    Nonprescription Medications for Adults With Allergic Rhinitis.
    JAMA. 2023 Dec 21. doi: 10.1001/jama.2023.20171.


  53. DRUCKER NA, Cox CS Jr
    Adult presentation of congenital tracheooesophageal fistula treated as asthma and recurrent respiratory infections.
    Lancet. 2023;402:2326-2327.

    PLoS One

  54. LEE IS, Yeom M, Kim K, Hahm DH, et al
    Correction: Prediction of disease severity using serum biomarkers in patients with mild-moderate Atopic Dermatitis: A pilot study.
    PLoS One. 2023;18:e0296370.
    PubMed         Abstract available

  55. ISLAM R, Ahmed S, Chakma SK, Mahmud T, et al
    Smoking and pre-existing co-morbidities as risk factors for developing severity of COVID-19 infection: Evidence from a field hospital in a rural area of Bangladesh.
    PLoS One. 2023;18:e0295040.
    PubMed         Abstract available

  56. KADYROVA N, Gotham D, Kniazkov S, Aghayev E, et al
    Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021.
    PLoS One. 2023;18:e0294680.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  57. WEN J, Heft-Neal S, Baylis P, Boomhower J, et al
    Quantifying fire-specific smoke exposure and health impacts.
    Proc Natl Acad Sci U S A. 2023;120:e2309325120.
    PubMed         Abstract available

    Respir Med

  58. SUN Y, Jiang F, Li R, Xiao L, et al
    The future landscape of immunology in COPD: A bibliometric analysis.
    Respir Med. 2023;220:107462.
    PubMed         Abstract available

  59. SUN Y, Zhang Y, Bai W, Liu X, et al
    Relationship between depression severity and respiratory symptoms in US adults: A national cross-sectional study.
    Respir Med. 2023;220:107451.
    PubMed         Abstract available

  60. QUADFLIEG K, Machado A, de Lima FF, Dederen A, et al
    Physical status, symptoms and health-related quality of life during a severe exacerbation of COPD: Recovery and discriminative capacity for future events.
    Respir Med. 2023;220:107437.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.